Check out the options these frauds received this month. The link is below. It's truly sickening how failure at the exec level is rewarded so handsomely here. The more reps they let go the more money they receive. I guess that corny phrase Be Well only applies to them because all is not well if you are below a band 4.
http://finance.yahoo.com/q/it?s=MRK+Insider+Transactions
truly disgusting...calling them frauds is being pretty kindly...
They should all be thrown in jail for theft.
Hell..Willie Deese should be fired long ago for incompetnece with the manufacturing in such a shit shape! That guy is an idiot, a perfect example of affirmative action disgrace! He should be given the option to jump off the boat or be pushed!
You should have seen a specialty team managers meeting the week before last- threw all their reps under the bus ever day and partied like rock stars at night. One of the bar receipts was 4,000 for all the champagne.
Hell..Willie Deese should be fired long ago for incompetnece with the manufacturing in such a shit shape! That guy is an idiot, a perfect example of affirmative action disgrace! He should be given the option to jump off the boat or be pushed!
There is a recent article in the Harvard Business Review about Merger & Acquisition that you should all read.
The Big Idea: The New M&A Playbook
by Clayton M. Christensen, Richard Alton, Curtis Rising, and Andrew Waldeck
March 2011 issue
You will find out how these gentlemen made a bloody strategic mess when they decided to acquire Schering-Plough:
"Industry leaders like Pfizer, GSK, and Merck have tried to boost the output of their troubled business models by buying and integrating the products and pipeline resources of competing drugmakers. But in the wake of such acquisitions, Pfizer’s share price plummeted 40%. A far better strategy would be to focus on the place in the value chain that is becoming decommoditized: the management of clinical trials, which are now an integral part of the drug research process and so a critical capability for pharmaceutical companies. Despite this, most drugmakers have been outsourcing their clinical trials to contract research organizations such as Covance and Quintiles, better positioning those companies in the value chain. Acquiring those organizations, or a disruptive drugmaker like Dr. Reddy’s Laboratories, would help reinvent big pharma’s collapsing business model."
They were paid millions to burn billions of company money. Now, this strategic mistake is being accentuated operationally by the failure of Vorapaxar in the clinics, and the high degree of uncertainty surrounding the arbitration for remicade/simponi.
On top of this mess, please remember that there are 15,000 laid off employees carrying the pain and shame of unemployment for the executives of the new Merck to enjoy their mega salary and bonuses.
There is no need to be angry, it's life, but I long for justice.
Merck's purchase of SGP was nothing more than a distraction from their master plan of reducing headcount. The layoffs were only part of it; the pressure games to force out senior reps across the country were ramped up significantly in 2010. Our company is a disgrace to those of us perceptive enough to see the truth. Merck disgusts me.
Check out the options these frauds received this month. The link is below. It's truly sickening how failure at the exec level is rewarded so handsomely here. The more reps they let go the more money they receive. I guess that corny phrase Be Well only applies to them because all is not well if you are below a band 4.
http://finance.yahoo.com/q/it?s=MRK+Insider+Transactions
